Efficacy and Mechanism of Dapagliflozin in Alport Syndrome: TH-PO469
Gespeichert in:
| Veröffentlicht in: | Journal of the American Society of Nephrology 2023-11, Vol.34 (11S), p.220-220 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 220 |
|---|---|
| container_issue | 11S |
| container_start_page | 220 |
| container_title | Journal of the American Society of Nephrology |
| container_volume | 34 |
| creator | Zheng, Qimin Yu, Shuwen Jun, Tong Jin, Yuanmeng Fang, Zhengying Weng, Qinjie Du, Wen Li, Junru Xiaoxia, Pan Gu, Xiangchen Xie, Jingyuan |
| description | |
| doi_str_mv | 10.1681/ASN.20233411S1220b |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1681_ASN_20233411S1220b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1681_ASN_20233411S1220b</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1681_ASN_20233411S1220b3</originalsourceid><addsrcrecordid>eNqdzr0KwjAYheEMCtafG3DKDbTmS2sqbkUrLrrUPcQ00UjalMSlXr0VXFyFA-904EFoCSQBtoFVUZ0TSmiaZgAVUEquIxQByVjMWJ5O0DSEByGwpnkeoW2ptZFC9li0NT4peRetCQ12Gu9FJ27WaOtepsXDCts5_8RV39beNWqOxlrYoBbfzhA9lJfdMZbeheCV5p03jfA9B8I_Mj7I-K8s_ev0BtHZQys</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Efficacy and Mechanism of Dapagliflozin in Alport Syndrome: TH-PO469</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Zheng, Qimin ; Yu, Shuwen ; Jun, Tong ; Jin, Yuanmeng ; Fang, Zhengying ; Weng, Qinjie ; Du, Wen ; Li, Junru ; Xiaoxia, Pan ; Gu, Xiangchen ; Xie, Jingyuan</creator><creatorcontrib>Zheng, Qimin ; Yu, Shuwen ; Jun, Tong ; Jin, Yuanmeng ; Fang, Zhengying ; Weng, Qinjie ; Du, Wen ; Li, Junru ; Xiaoxia, Pan ; Gu, Xiangchen ; Xie, Jingyuan</creatorcontrib><identifier>ISSN: 1046-6673</identifier><identifier>DOI: 10.1681/ASN.20233411S1220b</identifier><language>eng</language><ispartof>Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.220-220</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Zheng, Qimin</creatorcontrib><creatorcontrib>Yu, Shuwen</creatorcontrib><creatorcontrib>Jun, Tong</creatorcontrib><creatorcontrib>Jin, Yuanmeng</creatorcontrib><creatorcontrib>Fang, Zhengying</creatorcontrib><creatorcontrib>Weng, Qinjie</creatorcontrib><creatorcontrib>Du, Wen</creatorcontrib><creatorcontrib>Li, Junru</creatorcontrib><creatorcontrib>Xiaoxia, Pan</creatorcontrib><creatorcontrib>Gu, Xiangchen</creatorcontrib><creatorcontrib>Xie, Jingyuan</creatorcontrib><title>Efficacy and Mechanism of Dapagliflozin in Alport Syndrome: TH-PO469</title><title>Journal of the American Society of Nephrology</title><issn>1046-6673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqdzr0KwjAYheEMCtafG3DKDbTmS2sqbkUrLrrUPcQ00UjalMSlXr0VXFyFA-904EFoCSQBtoFVUZ0TSmiaZgAVUEquIxQByVjMWJ5O0DSEByGwpnkeoW2ptZFC9li0NT4peRetCQ12Gu9FJ27WaOtepsXDCts5_8RV39beNWqOxlrYoBbfzhA9lJfdMZbeheCV5p03jfA9B8I_Mj7I-K8s_ev0BtHZQys</recordid><startdate>202311</startdate><enddate>202311</enddate><creator>Zheng, Qimin</creator><creator>Yu, Shuwen</creator><creator>Jun, Tong</creator><creator>Jin, Yuanmeng</creator><creator>Fang, Zhengying</creator><creator>Weng, Qinjie</creator><creator>Du, Wen</creator><creator>Li, Junru</creator><creator>Xiaoxia, Pan</creator><creator>Gu, Xiangchen</creator><creator>Xie, Jingyuan</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202311</creationdate><title>Efficacy and Mechanism of Dapagliflozin in Alport Syndrome</title><author>Zheng, Qimin ; Yu, Shuwen ; Jun, Tong ; Jin, Yuanmeng ; Fang, Zhengying ; Weng, Qinjie ; Du, Wen ; Li, Junru ; Xiaoxia, Pan ; Gu, Xiangchen ; Xie, Jingyuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1681_ASN_20233411S1220b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Qimin</creatorcontrib><creatorcontrib>Yu, Shuwen</creatorcontrib><creatorcontrib>Jun, Tong</creatorcontrib><creatorcontrib>Jin, Yuanmeng</creatorcontrib><creatorcontrib>Fang, Zhengying</creatorcontrib><creatorcontrib>Weng, Qinjie</creatorcontrib><creatorcontrib>Du, Wen</creatorcontrib><creatorcontrib>Li, Junru</creatorcontrib><creatorcontrib>Xiaoxia, Pan</creatorcontrib><creatorcontrib>Gu, Xiangchen</creatorcontrib><creatorcontrib>Xie, Jingyuan</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Qimin</au><au>Yu, Shuwen</au><au>Jun, Tong</au><au>Jin, Yuanmeng</au><au>Fang, Zhengying</au><au>Weng, Qinjie</au><au>Du, Wen</au><au>Li, Junru</au><au>Xiaoxia, Pan</au><au>Gu, Xiangchen</au><au>Xie, Jingyuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and Mechanism of Dapagliflozin in Alport Syndrome: TH-PO469</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><date>2023-11</date><risdate>2023</risdate><volume>34</volume><issue>11S</issue><spage>220</spage><epage>220</epage><pages>220-220</pages><issn>1046-6673</issn><doi>10.1681/ASN.20233411S1220b</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1046-6673 |
| ispartof | Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.220-220 |
| issn | 1046-6673 |
| language | eng |
| recordid | cdi_crossref_primary_10_1681_ASN_20233411S1220b |
| source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
| title | Efficacy and Mechanism of Dapagliflozin in Alport Syndrome: TH-PO469 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T10%3A16%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20Mechanism%20of%20Dapagliflozin%20in%20Alport%20Syndrome:%20TH-PO469&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Zheng,%20Qimin&rft.date=2023-11&rft.volume=34&rft.issue=11S&rft.spage=220&rft.epage=220&rft.pages=220-220&rft.issn=1046-6673&rft_id=info:doi/10.1681/ASN.20233411S1220b&rft_dat=%3Ccrossref%3E10_1681_ASN_20233411S1220b%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |